From the pathophysiological aspect, atherosclerosis initiates from disrupted endothelium which allows circulating apolipoprotein B (apoB)-containing lipoproteins to penetrate and accumulate in subendothelium where they further undergo chemical modification. Here, APOB is linked to atherosclerosis.